Kits Research And Ddevelopement To Revenue from 2010 to 2024
| KITS Stock | CAD 8.95 0.24 2.61% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.008546 | Current Value 0.00949 | Quarterly Volatility 0.00052985 |
Check Kits Eyecare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kits Eyecare's main balance sheet or income statement drivers, such as Interest Income of 352.2 K, Interest Expense of 1.6 M or Selling General Administrative of 12.8 M, as well as many indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0 or PTB Ratio of 4.0. Kits financial statements analysis is a perfect complement when working with Kits Eyecare Valuation or Volatility modules.
Kits | Research And Ddevelopement To Revenue |
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.